3 Penny Stocks Making Huge Moves Higher

GHSI shares have almost tripled at last check

Jul 17, 2019 at 1:22 PM
facebook twitter linkedin

U.S. stocks are trading in the red today, putting the Dow's win streak in danger. Three penny stocks to watch in today's trading are retailer Francesca's Holdings Corp (NASDAQ:FRAN), CAR-T specialist Anixa Biosciences Inc (NASDAQ:ANIX), and eye care name Guardion Health Sciences Inc (NASDAQ:GHSI). Here's a breakdown of how the shares of FRAN, ANIX, and GHSI are trading. 

New Investor Boosts FRAN

FRAN shares were last seen up 14.7% at $3.89, thanks to news Cross River Capital has taken a stake in the company. The move comes after the stock has posted an epic sell-off in the past 12 months, falling from around $90 to a low of $3.27 yesterday. What's more, the equity earlier topped out below the 50-day moving average, a trendline that's been a ceiling on the charts since February.

Not surprisingly, short interest is extremely elevated on Francesca's. Data shows more than 34% of the float tied up in short interest, which would take more than three weeks to cover, based on average daily trading volumes.

Cleveland Clinic Partnership Boosts Anixa

ANIX stock has gained 18.2% to trade at $4.88, after the company said it's teaming up with the Cleveland Clinic to work on a breast cancer vaccine. However, the shares topped out in the low $5 region that capped their last breakout attempt in February. Analysts, though, still have high hopes, indicated by the equity's average 12-month price target of $11.25 -- territory Anixa hasn't touched since early 2014.

Guardion Health Sciences More Than Doubles

The shares of GHSI have surged 180% on news the company's MapcatSF device, which is meant to help in treating multiple eye conditions, has received a patent. The stock has only been on the public markets since April, and today is eyeing its best close since April 18, last seen at $2.69. It originally opened for trading at $3.80 and last week hit its lowest point of 90 cents. The security has yet to pick up any analyst attention.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Schaeffer's Daily Bulletin Offer


Special Offers from Schaeffer's Trading Partners